Family Medicine · Norfolk, NE
NPI
1194739912
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3901 W Norfolk Ave Ste D
Norfolk, NE, 68701
Phone (402) 844-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
6,513 services
Medicare patients, 2024
833
Average age 77
Drug cost, 2024
$2.3M
34,149 prescriptions
Company payments, 2025
$1,005
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bryon D Hirschman was code J0897 (injection, denosumab, 1 mg), 1,800 times for 17 patients. In total Bryon D Hirschman billed 6,513 services in 59 codes, and Medicare paid $206K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,800 | 17 | $19.57 | $35K |
| 99214 Office E&M - Established | Office | 1,469 | 675 | $77.38 | $114K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,040 | 12 | $0.09 | $91.37 |
| 85610 Clinical Chemistry | Office | 352 | 40 | $4.20 | $1,478 |
| 99213 Office E&M - Established | Office | 347 | 253 | $55.23 | $19K |
| 93793 Care Management/Coordination | Office | 337 | 41 | $7.43 | $2,504 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 256 | 46 | $0.74 | $189 |
| 96372 Injection Administration | Office | 150 | 60 | $8.74 | $1,311 |
| G0008 Administration of influenza virus vaccine | Office | 120 | 118 | $29.40 | $3,528 |
| 90662 Vaccine Product | Office | 117 | 115 | $73.47 | $8,596 |
| 69209 Other Organ Systems | Office | 80 | 69 | $8.72 | $698 |
| 99309 SNF E&M | Office | 62 | 52 | $32.88 | $2,038 |
| 81002 Clinical Chemistry | Office | 41 | 32 | $3.41 | $140 |
| 20610 Joint Injection | Office | 38 | 30 | $46.78 | $1,778 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 35 | 35 | $117.97 | $4,129 |
By year: 2022 $274K for 7,352 services; 2023 $277K for 7,336 services; 2024 $206K for 6,513 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 352 | 40 | $4.20 | $1,478 |
| 81002 Clinical Chemistry | 41 | 32 | $3.41 | $140 |
Medicare prescription drug claims, 2024
In 2024, the drug Bryon D Hirschman prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,719 prescriptions and refills. In total Bryon D Hirschman wrote 34,149 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,719 | 3,577 | 336 | $17K |
| Atorvastatin Calcium Generic | 1,608 | 3,512 | 347 | $18K |
| Losartan Potassium Generic | 1,278 | 2,804 | 281 | $14K |
| Potassium Chloride Generic | 1,085 | 1,753 | 230 | $18K |
| Omeprazole Generic | 966 | 2,054 | 212 | $12K |
| Pantoprazole Sodium Generic | 861 | 1,624 | 191 | $12K |
| Eliquis Apixaban | 806 | 1,003 | 107 | $465K |
| Amlodipine Besylate Generic | 793 | 1,777 | 188 | $5,389 |
| Furosemide Generic | 781 | 1,241 | 189 | $4,070 |
| Gabapentin Generic | 767 | 1,128 | 147 | $13K |
| Lisinopril Generic | 712 | 1,637 | 163 | $5,551 |
| Metoprolol Tartrate Generic | 699 | 1,433 | 155 | $4,913 |
| Tramadol Hcl Generic | 571 | 583 | 116 | $3,983 |
| Metoprolol Succinate Generic | 543 | 1,157 | 124 | $9,159 |
| Simvastatin Generic | 539 | 1,416 | 136 | $4,757 |
Brand drugs: 3,948 claims; generic drugs: 29,964 claims; opioid claims: 1,068.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bryon D Hirschman $1,005 ($1,005 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $254.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $254 |
| Pfizer Inc. PFE | 11 | $138 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $90.79 |
| Novo Nordisk Inc NVO | 5 | $86.4 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $75.44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $51.68 |
| Merck Sharp & Dohme LLC MRK | 3 | $45.54 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $34.07 |
| Eisai Inc. 4523.T | 2 | $33.97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $31.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.